SOP Guide for Pharma

Analytical Method Development: SOP for Handling Unplanned Instrument Downtime – V 2.0

Analytical Method Development: SOP for Handling Unplanned Instrument Downtime – V 2.0

Standard Operating Procedure for Managing Unplanned Instrument Downtime in Analytical Method Development


Department Analytical Method Development
SOP No. SOP/AMD/351/2025
Supersedes SOP/AMD/351/2022
Page No. Page 1 of 11
Issue Date 01/06/2025
Effective Date 03/06/2025
Review Date 01/06/2026

1. Purpose

This SOP defines the systematic approach for handling unplanned instrument downtime in the Analytical Method Development (AMD) laboratory. The objective is to ensure continuity of critical activities, minimize impact on analytical schedules, and maintain GMP compliance

through proper documentation, communication, and risk assessment.

2. Scope

This SOP applies to all major analytical instruments used in AMD such as HPLC, GC, UV, FTIR, dissolution apparatus, and balances. It includes procedures for reporting breakdowns, logging deviations, initiating service, and managing impacted analysis.

3. Responsibilities

  • Analyst: Immediately reports downtime to the Section Head and logs initial observations.
  • Section Head: Coordinates service request, reviews impact, and documents alternative arrangements.
  • QA Representative: Reviews deviation, verifies CAPA implementation, and closes investigation.
  • Engineering/Maintenance: Diagnoses, repairs, and provides instrument service report.

4. Accountability

The Head of Analytical Method Development is accountable for ensuring timely resolution of instrument downtime, regulatory reporting (if applicable), and implementation of preventive controls for future mitigation.

5. Procedure

5.1 Initial Identification and Reporting

  1. If an instrument fails to function properly or produces abnormal results (e.g., pressure fluctuations, noise, drift), stop analysis immediately.
  2. Record error message, instrument status, and any prior maintenance activities in the Instrument Downtime Log (Annexure-1).
  3. Inform the Section Head and mark the instrument as “Out of Service” with appropriate signage.

5.2 Impact Assessment

  1. Review pending and ongoing analytical work impacted by the downtime.
  2. Assess whether any batch release, stability study, or validation timelines will be affected.
  3. If applicable, initiate a deviation report (refer SOP/QA/Deviation/2025) and document the risk to data integrity.

5.3 Corrective Action and Service Request

  1. Contact internal engineering team or authorized vendor for immediate troubleshooting and repair.
  2. Record all interactions, service visit logs, replaced components, and downtime duration in Annexure-2.
  3. Only GMP-qualified personnel may conduct service on regulated instruments.

5.4 Temporary Analytical Arrangements

  1. If critical analysis is pending, request QA approval to use alternative validated instruments of the same make/model.
  2. Ensure method transfer verification, if applicable, is documented.
  3. Record details of interim arrangements in the analytical worksheet and final report.

5.5 Post-Service Qualification

  1. Once repaired, perform verification checks as per instrument-specific SOPs (e.g., calibration, system suitability).
  2. Conduct performance qualification (PQ) if critical hardware or firmware was replaced.
  3. QA must approve requalification before resuming routine use.

5.6 Documentation and Review

  1. Ensure all logs, service records, qualification data, and CAPA are attached to the deviation or breakdown file.
  2. QA must review and sign off all entries.
  3. Trends of recurring issues must be reviewed monthly for preventive maintenance planning.

6. Abbreviations

  • HPLC: High Performance Liquid Chromatography
  • GC: Gas Chromatography
  • QA: Quality Assurance
  • CAPA: Corrective and Preventive Action
  • PQ: Performance Qualification

7. Documents

  1. Annexure-1: Instrument Downtime Log
  2. Annexure-2: Instrument Service and Repair Record
  3. SOP/QA/Deviation/2025 – Deviation Handling

8. References

  • 21 CFR Part 211 – GMP for Finished Pharmaceuticals
  • ICH Q9 – Quality Risk Management
  • MHRA and WHO Guidelines on Laboratory Equipment Maintenance

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name Ritika Sharma Mayur Desai Dr. Nidhi Srivastava
Designation Analyst – AMD QA Reviewer Head – Analytical Method Development
Department Analytical Method Development Quality Assurance Analytical Method Development

11. Annexures

Annexure-1: Instrument Downtime Log

Date Instrument ID Description of Issue Action Taken Status
30/05/2025 HPLC-002 Detector not responding Vendor visit, replaced detector lamp Resolved

Annexure-2: Instrument Service and Repair Record

Instrument ID Service Date Engineer Name Details of Repair Next Calibration Due
HPLC-002 31/05/2025 Rajesh Patil Replaced lamp and recalibrated 31/08/2025

Revision History:

Revision Date Revision No. Details Reason Approved By
01/06/2025 2.0 Updated CAPA process and annexures Annual review Dr. Nidhi Srivastava
01/06/2022 1.0 Initial release New SOP QA Head
Exit mobile version